ARMGO PHARMA
ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on the sarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
ARMGO PHARMA
Social Links:
Industry:
Biotechnology Developer Platform Therapeutics
Founded:
2004-01-01
Address:
Tarrytown, New York, United States
Country:
United States
Website Url:
http://www.armgo.com
Total Employee:
11+
Status:
Active
Contact:
2129230316
Email Addresses:
[email protected]
Total Funding:
36 M USD
Technology used in webpage:
Amazon Person Schema Google Google Cloud Gravatar Profiles Amazon Virginia Region
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Series B - ARMGO Pharma
Pontifax
Pontifax investment in Series B - ARMGO Pharma
Kurma Partners
Kurma Partners investment in Series B - ARMGO Pharma
Official Site Inspections
http://www.armgo.com Semrush global rank: 7.33 M Semrush visits lastest month: 811
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ARMGO Pharma"
ARMGO Pharma - Crunchbase Company Profile
ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that …See details»
Under Construction - ARMGO
ARMGO is a venture-backed biotech company developing Rycals®, novel small molecule drugs that target the ryanodine receptor calcium ion channels (RyR). We will soon be sharing a new …See details»
ARMGO Pharma, Inc. - Drug pipelines, Patents, Clinical trials
Explore ARMGO Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 3 news, and 4 literature, Disease Domain:Nervous System Diseases, …See details»
ARMGO Pharma, Inc. - LinkedIn
ARMGO Pharma, Inc. | 483 followers on LinkedIn. First-in-Class Disease-Modifying Therapeutics in Cardiac and Skeletal Muscle Diseases | ARMGO is a venture-backed biotech company …See details»
Armgo Pharma Company Profile 2024: Valuation, …
Armgo Pharma was founded in 2004. Where is Armgo Pharma headquartered? Armgo Pharma is headquartered in Ardsley, NY. What is the size of Armgo Pharma? Armgo Pharma has 10 total employees. What industry is Armgo …See details»
Armgo Pharma, Inc - VentureRadar
" ARMGO Pharma, Inc., is a privately held biopharmaceutical company dedicated to applying targeted mechanism-based science to the development of novel small-molecule therapeutics …See details»
ARMGO Pharma - Contacts, Employees, Board Members
Organization. ARMGO Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Member and Advisor Profiles 4. Contacts 9. About. ARMGO …See details»
Armgo Pharma, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Armgo Pharma, Inc. of Tenafly, NJ. Get the latest business insights from Dun & Bradstreet.See details»
ARMGO Pharma, Inc. Company Profile - Office Locations ... - Craft
ARMGO Pharma is a biopharmaceutical company developing small-molecule therapeutics to treat cardiac, muscular, and neurological disorders. The company’s drugs are oral agents that act to …See details»
ARMGO,Pharma,Inc. - The Org
ARMGO Pharma develops small molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders.See details»
Armgo Pharma - Overview, News & Similar companies - ZoomInfo
Jan 3, 2022 ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia ARDSLEY, N.Y.--(BUSINESS …See details»
Armgo Pharma - Products, Competitors, Financials, Employees ...
Armgo Pharma is a venture-backed biotechnology company focused on developing small molecule drugs that target the ryanodine receptor calcium ion channels (RyR). Use the CB …See details»
Armgo Pharma CEO, Founder, Key Executive Team, Board of …
Armgo Pharma has 1 board of directors, including Andrew Schiff. Name. Firm. Work History. Other Seats. Andrew Schiff. Dr. Schiff joined Fund I in September of 1999 and has served as …See details»
ARMGO Pharma, Inc. CEO and Key Executive Team | Craft.co
ARMGO Pharma, Inc.'s President and Chief Medical Officer is Gene Marcantonio. See the full leadership team at Craft.See details»
ARMGO Pharma raises $35 million to progress clinical
Dec 20, 2021 Ardsley, New York, USA – 20th December 2021 – ARMGO Pharma Inc (“ARMGO”), a leading novel small molecule therapeutics company developing treatments for …See details»
ARMGO Pharma Publishes Positive Phase 1b Trial Results of …
ARDSLEY, N.Y., January 29, 2024 – ARMGO Pharma, Inc. (ARMGO), a clinical stage biopharmaceutical company advancing a novel class of small molecule drugs known as …See details»
ARMGO Pharma raises $35 million to progress clinical studies of …
Dec 20, 2021 ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by Forbion and …See details»
Armgo Pharma Raises $35M in Funding - FinSMEs
Jan 3, 2022 Armgo Pharma, an Ardsley, New York-based novel small molecule therapeutics company developing treatments for cardiac, musculoskeletal, and neurological disorders, …See details»
Armgo - Overview, News & Similar companies | ZoomInfo.com
Who is Armgo. ARMGO system is an innovative design solutions for the commercial, residential and DIY markets. Armgo system provides a wide range of solutions and world class training …See details»
Treatment of Catecholaminergic Polymorphic Ventricular …
Jul 19, 2023 addition, we are building our portfolio to strengthen ARMGO’s position as a pioneer of Rycal-based treatments for Ryanodine Receptor-related disorders.” ARMGO was granted …See details»